Michele Morari earned a BSc in Pharmacy from the University of Ferrara (Italy), and a PhD in Neuroscience from the Karolinska Institute (Stockholm, Sweden). He is currently Associate Professor of Pharmacology at the University of Ferrara where he leads a group of researchers focused on basal ganglia physiopathology and movement disorders. His main scientific interests revolve around the neurochemistry of basal ganglia in models of Parkinson’s disease and L-DOPA induced dyskinesia, with a focus on dopamine, glutamate, opioid transmission. Morari lab is involved in the neurochemical, biochemical and behavioural characterization of functional, neurodegeneration, and genetic models of Parkinson’s disease, among which include LRRK2 and Parkinsonian mice. Prof. Morari is co-Author of 118 papers in international peer-reviewed journals (H=36 Scopus) and serves as a member of the Editorial board of Biomedicines and Neurobiology of Disease.